Preclinical and clinical evaluation of farnesyltransferase inhibitors, Current Oncology Reports, vol.20, issue.2, pp.99-107, 2003. ,
DOI : 10.1007/s11912-003-0096-5
Characterization of the antitumour effects of the selective farnesyl protein transferase inhibitor R115777 in vivo and in vitro, Cancer Res, vol.61, pp.131-137, 2001. ,
Farnesyltransferase inhibitors and their potential in the treatment of breast carcinoma, Seminars in Oncology, vol.30, issue.5, pp.79-92, 2003. ,
DOI : 10.1053/j.seminoncol.2003.08.010
Breast cancer endocrine resistance: how growth factor signaling and estrogen receptor coregulators modulate response, Clin Cancer Res, vol.9, pp.447-454, 2003. ,
Multiple Targeting by the Antitumor Drug Tamoxifen: A Structure-Activity Study, Current Medicinal Chemistry-Anti-Cancer Agents, vol.4, issue.6, pp.491-508, 2004. ,
DOI : 10.2174/1568011043352696
URL : https://hal.archives-ouvertes.fr/inserm-00090772
High-affinity anti-oestrogen binding site distinct from the oestrogen receptor, Nature, vol.93, issue.5788, pp.273-275, 1980. ,
DOI : 10.1038/288273a0
Physicochemical and genetic evidence for specific antiestrogen binding sites., Proceedings of the National Academy of Sciences, vol.80, issue.11, pp.3158-3162, 1983. ,
DOI : 10.1073/pnas.80.11.3158
Molecular Characterization of the Microsomal Tamoxifen Binding Site, Journal of Biological Chemistry, vol.279, issue.32, pp.34048-34061, 2004. ,
DOI : 10.1074/jbc.M405230200
URL : https://hal.archives-ouvertes.fr/inserm-00090773
Cell proliferation kinetics of MCF-7 human mammary carcinoma cells in culture and effects of tamoxifen on exponentially growing and plateau-phase cells, Cancer Res, vol.43, pp.3998-4006, 1983. ,
Modifications of benzylphenoxy ethanamine antiestrogen molecules: influence affinity for antiestrogen binding site (AEBS) and cell cytotoxicity, Biochemical Pharmacology, vol.57, issue.6, pp.657-661, 1999. ,
DOI : 10.1016/S0006-2952(98)00347-5
URL : https://hal.archives-ouvertes.fr/inserm-00090781
Activation of caspase-3 and c-Jun NH2-terminal kinase-1 signaling pathways in tamoxifen-induced apoptosis of human breast cancer cells, Cancer Res, vol.60, pp.5995-6000, 2000. ,
Pharmacodynamics of tamoxifen and its 4-hydroxy and N-desmethyl metabolites: activation of caspases and induction of apoptosis in rat mammary tumours and in human breast cancer cell lines, Cancer Res, vol.60, pp.6601-6606, 2000. ,
Protein farnesylation in mammalian cells: effects of farnesyltransferase inhibitors on cancer cells, Cellular and Molecular Life Sciences, vol.58, issue.11, pp.1636-1649, 2001. ,
DOI : 10.1007/PL00000802
Additive effects of tamoxifen and the farnesyl transferase inhibitor FTI-277 on inhibition of MCF-7 breast cancer cell-cycle progression, International Journal of Cancer, vol.10, issue.5, pp.789-798, 2003. ,
DOI : 10.1002/ijc.11263
Contrasting Effects of Prenyltransferase Inhibitors on Estrogen-Dependent Cell Cycle Progression and Estrogen Receptor-Mediated Transcriptional Activity in MCF-7 Cells, Endocrinology, vol.144, issue.3, pp.989-998, 2003. ,
DOI : 10.1210/en.2002-220726
URL : https://hal.archives-ouvertes.fr/inserm-00090777
Synthesis, binding and structure???affinity studies of new ligands for the microsomal anti-estrogen binding site (AEBS), Bioorganic & Medicinal Chemistry, vol.8, issue.8 ,
DOI : 10.1016/S0968-0896(00)00119-X
URL : https://hal.archives-ouvertes.fr/inserm-00090778
New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening, JNCI Journal of the National Cancer Institute, vol.82, issue.13, pp.1107-1112, 1990. ,
DOI : 10.1093/jnci/82.13.1107
Exploitable mechanisms in combined radiotherapy-chemotherapy: The concept of additivity, International Journal of Radiation Oncology*Biology*Physics, vol.5, issue.1, pp.85-91, 1979. ,
DOI : 10.1016/0360-3016(79)90044-0
A diphenylmethane derivative selective for the anti-estrogen binding site may help define its biological role, Biochemical and Biophysical Research Communications, vol.124, issue.1, pp.244-249, 1984. ,
DOI : 10.1016/0006-291X(84)90943-4
Tamoxifen Is a Potent Inhibitor of Cholesterol Esterification and Prevents the Formation of Foam Cells, Journal of Pharmacology and Experimental Therapeutics, vol.308, issue.3, 2003. ,
DOI : 10.1124/jpet.103.060426
URL : https://hal.archives-ouvertes.fr/inserm-00090774
Tamoxifen and the Farnesyl Transferase Inhibitor FTI-277 Synergize to Inhibit Growth in Estrogen Receptor-Positive Breast Tumor Cell Lines, Breast Cancer Research and Treatment, vol.60, issue.1, pp.59-67, 2003. ,
DOI : 10.1023/A:1022105511409
Proteintyrosine phosphatase PTPL1/FAP-1 triggers apoptosis in human breast cancer cells ,
Cdk inhibitors, roscovitine and olomoucine, synergize with farnesyltransferase inhibitor (FTI) to induce efficient apoptosis of human cancer cell lines, Oncogene, vol.19, issue.27, pp.3059-3068, 2000. ,
DOI : 10.1038/sj.onc.1203625
The Promoter of the Rat 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Gene Contains a Tissue-Specific Estrogen-Responsive Region, Molecular Endocrinology, vol.13, issue.8, pp.1225-1236, 1999. ,
DOI : 10.1210/mend.13.8.0333
Induction of apoptosis in human mammary carcinoma cells by (4-cumyl-phe- noxy)-ethyl-N-pyrrolidine-HCl, 92nd Annual Meeting of the Proceedings of the American Association for Cancer Research, pp.24-28, 2001. ,
A phase I trial and pharmacokinetic study of tipifarnib, a farnesyltransferase inhibitor, and tamoxifen in metastatic breast cancer, Clin Cancer Res, vol.11, pp.1247-1252, 2005. ,
New targets for therapy in breast cancer: Farnesyltransferase inhibitors, Breast Cancer Research, vol.23, issue.6, pp.262-268, 2004. ,
DOI : 10.1158/1078-0432.CCR-03-0412
-Diethyl-2-[4-(Phenylmethyl) Phenoxy]Ethanamine (BMS-217380-01) Combined With Doxorubicin Versus Doxorubicin Alone in Metastatic/Recurrent Breast Cancer: National Cancer Institute of Canada Clinical Trials Group Study MA.19, Journal of Clinical Oncology, vol.22, issue.2, pp.269-276, 2004. ,
DOI : 10.1200/JCO.2003.04.075